Intravenous administration of N-acetylcysteine reduces plasma total homocysteine levels in renal transplant recipients

Annals of Transplantation

Volumn 14, Issue 4, 2009, Pages 5-9

  Rymarz, Aleksandra ^a   Durlik, Marek ^a,b   Rydzewski, Andrzej ^a,b,c  

^a CSK MSWiA ^*  (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c JAN KOCHANOWSKI UNIVERSITY   (Poland)

Author keywords

Homocysteine; N acetylcysteine; Renal transplantation

Indexed keywords

ACETYLCYSTEINE; CYANOCOBALAMIN; CYCLOSPORIN; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; FOLIC ACID BLOOD LEVEL; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT; MALE; PROTEIN BLOOD LEVEL;

ACETYLCYSTEINE; ADULT; ANALYSIS OF VARIANCE; CREATININE; CROSS-OVER STUDIES; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION;

EID: 74949093501     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ducloux D, Motte G. Challier Bel al: Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study. J Am Soc Nephrol, '2000; 11:134
2. Marcucci R, Zanazzi M, Bertoni E el al: Risk factors for cardiovascular disease in renal transplant recipients: new insights. Transpl Int, 2000; 13(Suppl.1): S419
3. Shermin D, Boslom AC, SelhubJ: Treatment of hyperhomocysteinemia in end-stage renal disease, Am J Kidney Dis, 2001; 38: S91
4. Winkelmayer WC. Kramar R. Curhan GC et al: Fasting plasma tolal homocysteine levels and mortality and allograft, loss in kidney transplant recipients: a prospective study. J Am Soe Nephrol, 2005: 16: 255
5. Bostom AC. Shemin D, Gohh RY et al: Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients, kidney Int Suppl, 2001; 78: S246
6. Bostom AG,Shemin D, Gohh RY el ai: Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis palienls. Transplantation, 2000; 69: 2128
7. Xu T, Zhang XW, Qu XK el al: Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population. J Urol, 2008: 179: 1190
8. Ventura P, Panini R, Pasini MC el al: N-Acetylcysteine reduces homocysteine plasma levels after single intravenous administration bv increasing thiols urinary escretion. Pharmacol Res, 1999; 40: 345
9. Ventura P, Panini R, Abbati G el al: Urinary and plasma Homocysteine and cysteine levels during prolonged oral N-acytylcysteine therapy. Pharmacology, 2003; 68: 105
10. Hultberg B, Andersson A, Masson P et al: Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine. Scand J Clin Lab Invest. 1994; 54: 417
11. Miner SL, Cole DE, Evrovski J et al: N-acetylcysteine neither lowers plasma homocysteine concentrations nor improves brachial artery endothelial function in cardiac transplant recipients. Can J Cardiol, 2002: 18:503
12. Cockcroft DW, Gauh MH: Prediction of creatinine clearance from serum creatinine. Nephron, 1976; 10: 31
13. Bostotom AG. Shemin D, Yoburu D et al: lack of effect ol oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patients. Atherosclerosis, 1996: 120:241
14. Friedman AN, Bostom AG, Laliberty P el al: The effect of N-acelylcysieine on plasma total homocysteine lewis in hemodialysis: a randomized, controlled Study. Am J Kidney Dis. 2003: 41: 442
15. Scholze A, Rinder C, Beige J et al: Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stage renal failure. Circulation 2004; 109: 369
16. Thalia M, Yogiantoro M, Toinino Y: Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease. Clin Drug Investig, 2006; 26: 195
17. Tepel M, van der Giet M, Statz M el al: The antioxidant acetylcysteine reduces cardiovascular events in patients with end-slage renal failure: a randomized. controlled trial. Circulation, 2003: 107: 992
18. Gariboito G, Sofia A. Sallioti S et al: Interororgan exchange of aminothiols in humans. Am J Physiol Encorinol Metab, 2003; 284: E757
19. Bostom A, Brosnan JT Hall B et al: Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis, 1995: 116: 59
20. van Guldener C, Denker AJ, Jakobs C et al: No net renal extraction of homocysteine in fasting humans. Kidney Int, 1998:54: 166
21. Atnbrosi P, Barlatier A, Habib G et al: Hyperhomocystenaemina in heart transplant recipients. Eur Heart J. 1994; 15: 1191
22. Giannetti N, Herity NA. Alimollah A el al: Mild hvperhomocisiememia is not associated with cardiac allograft coronary disease. Clin Transplant. 2001; 15:247
23. Miner SE, Cole DE, Evrovski J el al: Hyperhomocysteinemia and transplant coronary arteny disease in cardiac transplant recipients. Clin Transplant, 20021; 15:258
24. Juskowa J, Bartiomiejczvk J, Paczek L el al: Total homocysteine as a risk factor for vascular disease in renal transplant recipients, Pransplant Proc. 2002; 34: 576
25. Dimeny E, Hultberg B, Wahlberg J et al: Serum total homocysteine concentration does not predict outcome in renal transplant, recipients. Clin Transplant., 1998; 12:563
26. Ambrosi P, Garcon D, Riberi A et al: Association of mild hyperhomocysteinemia with cardiac graft vascular disease. Atherosclerosis. 1998; 138: 347
27. Bostom AG, Gohh RY, Beaulieu AJ et al: Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients. Transplantation, 1999; 68: 257
28. Cooke GE, Eaton GM, Whitby G el al: Plasma atherogenic markers in congestive heart failure and postransplant (heart) patients. J Am Coll Cardiol, 2000; 36: 509
29. Rassoul F, Richter V, Junke C el al: Plasma homo-cysteine and lipoprotein prolile in patients with peripheral arterial occlusive disease. Angiology, 2000; 51: 189
30. Di Giorno C, Pinheiro HS, Heinke T et al: Beneficial effect of N-acetyl-cysteine on renal injury triggered bv ischemia and reperfusion. Transplant Proc, 2006; 38: 2774